IR@PKUHSC  > 北京大学基础医学院  > 免疫学系
学科主题基础医学
CMTM1_v17 is a novel potential therapeutic target in breast cancer
Wang, Jing1,2; Zhang, Guoying1,3; Zhang, Yingmei1,3; Luo, Yang1,3; Song, Quansheng1,3; Qiu, Xiaoyan1,3; Mo, Xiaoning1,3; Wang, Lu1,3
关键词CMTM1_v17 therapeutic target breast cancer tumor necrosis factor-alpha apoptosis
刊名ONCOLOGY REPORTS
2014-11-01
DOI10.3892/or.2014.3429
32期:5页:1829-1836
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]CHEMOKINE-LIKE FACTOR ; MOLECULAR-CLONING ; CELL GROWTH ; GENE ; IDENTIFICATION ; METHYLATION ; EXPRESSION ; ISOFORMS ; TESTIS
英文摘要

Chemokine-like factor (CKLF)-like MARVEL transmembrane domain-containing 1 (CMTM1) consists of at least 23 alternatively spliced isoforms designated CMTM1_v1-v23. In the present study, we detected CMTM1_v17 expression in multiple human normal and tumor tissues and found that CMTM1_v17 was highly expressed in testis and many tumor tissues including breast tumor. The overexpression of CMTM1_v17 in the breast cancer cell line MDA-MB-231 promoted cell proliferation and resistance to tumor necrosis factor-alpha (TNF-alpha)-induced apoptosis. Moreover, siRNA-mediated silencing of CMTM1_v17 sensitized MDA-MB-231 cells to TNF-alpha-induced apoptosis. We propose that CMTM1_v17 may be a novel potential target for therapy in breast cancer patients. The present study provides insight into a novel mechanism by which CMTM1_v17 enhances cellular proliferation and abrogates TNF-alpha-induced apoptosis. These findings also have implications for clinical practice as they highlight the potential for therapeutic targeting of CMTM1_v17 for the treatment of breast and other cancers in which CMTM1_v17 impacts cellular proliferation and survival.

语种英语
WOS记录号WOS:000342714000010
项目编号91129707 ; 81172001
资助机构National Natural Science Foundation of China
引用统计
被引频次:1[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
版本出版稿
条目标识符http://ir.bjmu.edu.cn/handle/400002259/52154
专题北京大学基础医学院_免疫学系
北京大学基础医学院
作者单位1.Peking Univ, Sch Basic Med Sci, Dept Immunol, Ctr Human Dis Genom, Beijing 100191, Peoples R China
2.Capital Med Univ, Beijing Shijitan Hosp, Dept Clin Lab, Beijing 100038, Peoples R China
3.Peking Univ, Sch Basic Med Sci, Key Lab Med Immunol, Minist Hlth, Beijing 100191, Peoples R China
推荐引用方式
GB/T 7714
Wang, Jing,Zhang, Guoying,Zhang, Yingmei,et al. CMTM1_v17 is a novel potential therapeutic target in breast cancer[J]. ONCOLOGY REPORTS,2014,32(5):1829-1836.
APA Wang, Jing.,Zhang, Guoying.,Zhang, Yingmei.,Luo, Yang.,Song, Quansheng.,...&Wang, Lu.(2014).CMTM1_v17 is a novel potential therapeutic target in breast cancer.ONCOLOGY REPORTS,32(5),1829-1836.
MLA Wang, Jing,et al."CMTM1_v17 is a novel potential therapeutic target in breast cancer".ONCOLOGY REPORTS 32.5(2014):1829-1836.
条目包含的文件
文件名称/大小 文献类型 版本类型 开放类型 使用许可
or_32_5_1829_PDF.pdf(928KB)期刊论文出版稿开放获取CC BY-NC-SA浏览 请求全文
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang, Jing]的文章
[Zhang, Guoying]的文章
[Zhang, Yingmei]的文章
百度学术
百度学术中相似的文章
[Wang, Jing]的文章
[Zhang, Guoying]的文章
[Zhang, Yingmei]的文章
必应学术
必应学术中相似的文章
[Wang, Jing]的文章
[Zhang, Guoying]的文章
[Zhang, Yingmei]的文章
相关权益政策
暂无数据
收藏/分享
文件名: or_32_5_1829_PDF.pdf
格式: Adobe PDF
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。